Previous 10 | Next 10 |
Shares of Alzamend Neuro (ALZN -14.0%), which were up 35% in the prior five trading sessions, are taking a breather today. Shares rose 28% alone yesterday after its ticker was one of the most mentioned on Twitter. The company's lead asset, AL001, is in IND-enabling stage f...
Gainers: Biofrontera (NASDAQ:BFRI) +26%, Gemini Therapeutics (NASDAQ:GMTX) +19%, Vir Biotechnology (NASDAQ:VIR) +14%, Mesoblast (NASDAQ:MESO) +14%, Tandem Diabetes Care (NASDAQ:TNDM) +10% Losers: Atai Life Sciences (NASDAQ:ATAI) -24%, Alzamend...
Palm Beach, FL – December 15, 2021 – FinancialNewsMedia.com News Commentary – Acute Myeloid Leukemia (AML) is a type of blood cancer which usually affects white blood cells (WBCs), however, it can also start in other types of blood-forming cells. In AML, the...
Alzamend Neuro (NASDAQ:ALZN) -13%. MIND Technology (NASDAQ:MIND) -10%. Livent (NYSE:LTHM) -8%. Nuverra Environmental Solutions (NYSE:NES) -7%. Entegris (NASDAQ:ENTG) -6% to acquire CMC Materials in a cash and stock transaction worth $6.5B. Leslie's (NASDAQ:LESL) -6% after price...
Shares of Alzamend Neuro (NASDAQ: ALZN) surged 28% on Tuesday, as investors bought in ahead of the biotech's upcoming clinical data release for its experimental Alzheimer's treatment. Alzamend is an early stage biopharmaceutical company focused on creating therapies for neur...
Gainers: Galera Therapeutics (NASDAQ:GRTX) +106%. Nuverra Environmental Solutions (NYSE:NES) +33%. CPS Technologies (NASDAQ:CPSH) +24%. Terminix (NYSE:TMX) +21%. Alzamend Neuro (NASDAQ:ALZN) +17%. MIND Technology (NASDAQ:MIND) +17%. Landec Corporation (NASDAQ:LNDC) +13%. Soliton (NASDAQ:SOLY)...
Adding a fifth in value, Alzamend Neuro (ALZN +20.0%) has continued its rally for the second straight session as investor interest on the micro-cap stock surged in morning hours. According to sites that track mentions of ticker symbols, Alzamend (NASDAQ:ALZN) was among the top five highl...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Galera Therapeutics (NASDAQ: GRTX ) stock is rocketing higher on Tuesday after the cancer treatment company revealed corrected results from a Phase 3 clinical trial. Source: Bukhta Yurii / Shutterstock.com Acc...
Penny Stocks With High Hopes From Analysts If you’re looking for penny stocks to buy, there are plenty of things to research. You could hunt for low float stocks, companies with news, insider trading activity, or, like we’ll look at today, penny stocks with bullish analyst...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Mind Technology (NASDAQ: MIND ) stock is taking off on Tuesday after the company announced an agreement with the U.S. Navy. Source: WorldStock / Shutterstock.com Specifically, Mind Technology has entered into ...
News, Short Squeeze, Breakout and More Instantly...
AstraZeneca PLC (AZN) is expected to report $0.97 for Q2 2024 BJ's Restaurants Inc. (BJRI) is expected to report $0.49 for Q2 2024 Baker Hughes Company (BKR) is expected to report $0.49 for Q2 2024 BlueHarbor Bank (BLHK) is expected to report for Q2 2024 Betterware de Mexico S.A.P...
Alzamend Neuro, Inc. (Nasdaq: ALZN) (“ Alzamend ”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“ Alzheimer’s ”), bipolar disorder (“ BD ”), major de...
Investor had agreed to purchase up to $25 million of preferred shares Alzamend expects to use proceeds to further its clinical trials and working capital purposes Alzamend Neuro, Inc. (Nasdaq: ALZN) (“ Alzamend ”), a clinical-stage biopharmaceutical compa...